Core Viewpoint - Guangzhou Maipu Regenerative Medicine Technology Co., Ltd. is planning a major asset restructuring involving the acquisition of 100% equity of Guangzhou Yijie Medical Technology Co., Ltd. through a combination of share issuance and cash payment, along with fundraising for related transactions [2]. Shareholding Situation - As of May 21, 2025, the top ten shareholders of the company hold only ordinary shares, with specific names and shareholding ratios disclosed [3]. - The top ten circulating shareholders also hold only ordinary shares, with their respective shareholding quantities and proportions provided [3][5]. Shareholder Details - The top shareholder is Beijing Fengyan Investment Management Co., Ltd. - Beijing Fengyan Ruiying No. 3 Private Securities Investment Fund, holding a significant number of shares [3]. - Other notable shareholders include China Industrial and Commercial Bank - China Europe Medical Health Mixed Securities Investment Fund and Huatai Securities Asset Management [3]. Documentation - The shareholder list is based on the records issued by China Securities Depository and Clearing Co., Ltd. [5].
迈普医学: 关于筹划重大资产重组停牌前一个交易日前十大股东和前十大流通股股东持股情况的公告